“Telmisartan Attenuates Experimental Liver Fibrosis Through Suppression Of Hepatic Stellate Cell Activation And Tgf-Β/Smad Signaling”, Rev Diabet Stud, pp. 496–510, Dec. 2025, doi: 10.70082/y1zx3j95.